Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-156046
Filing Date
2024-06-06
Accepted
2024-06-06 16:05:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4850
  Complete submission text file 0001193125-24-156046.txt   5875
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)